Journal of Applied Physiology, Vol 67, Issue 4 1569-1577, Copyright © 1989 by American Physiological Society

ARTICLES

Rabbit hindlimb glucose uptake assessed with positron-emitting fluorodeoxyglucose

K. A. Mossberg, R. W. Rowe, T. J. Tewson and H. Taegtmeyer
Department of Medicine, University of Texas Health Science Center, Houston 77030.

The feasibility of estimating skeletal muscle glucose uptake in vivo was examined by using the glucose analogue 2-[18F]deoxy-2-fluoro-D-glucose (2-[18F]FDG) in the rabbit hindlimb. A pair of collimated coincidence gamma photon detectors was used to monitor the accumulation of tracer in the tissue after 2-[18F]FDG injection. Time-activity curves were generated on a second-by-second basis under control conditions, during increased contractile activity, or hyperinsulinemia. The arterial input of 2-[18F]FDG, plasma glucose, lactate, free fatty acids, and insulin were determined. A graphical (Patlak plot) procedure was used to determine the fractional rate of tracer phosphorylation and therefore trapping in the muscle. From the graphical analysis, the estimated rate of glucose phosphorylation (R) in the unperturbed state was calculated to be 0.037 mumol.min-1.ml-1 of tissue. During perturbation by electrical stimulation, an increase in the rate of tracer phosphorylation (K) was observed. No change in the rate of tracer phosphorylation was observed during hyperinsulinemia. The results support the use of 2-[18F]FDG and the graphical procedure for the noninvasive assessment of glucose uptake by skeletal muscle in vivo. The method described is sensitive to changes in the rate of tracer uptake with respect to time and physiological interventions.

This article has been cited by other articles:

				S. Yamaguchi, H. Rikimaru, K. Yamaguchi, M. Itoh, and M. Watanabe Overall Activity of All Masticatory Muscles during Lateral Excursion J. Dent. Res., January 1, 2006; 85(1): 69 - 73. [Abstract] [Full Text] [PDF]

				I. Yokoyama, K. Yonekura, T. Moritan, M. Tateno, T. Momose, K. Ohtomo, Y. Inoue, and R. Nagai Troglitazone Improves Whole-Body Insulin Resistance and Skeletal Muscle Glucose Use in Type II Diabetic Patients J. Nucl. Med., July 1, 2001; 42(7): 1005 - 1010. [Abstract] [Full Text] [PDF]

				A. Legrand, S. Goldman, P. Damhaut, and A. De Troyer Heterogeneity of metabolic activity in the canine parasternal intercostals during breathing J Appl Physiol, March 1, 2001; 90(3): 811 - 815. [Abstract] [Full Text] [PDF]

				P. Peltoniemi, P. Lonnroth, H. Laine, V. Oikonen, T. Tolvanen, T. Gronroos, L. Strindberg, J. Knuuti, and P. Nuutila Lumped constant for [18F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans Am J Physiol Endocrinol Metab, November 1, 2000; 279(5): E1122 - E1130. [Abstract] [Full Text] [PDF]

				T. Utriainen, S. Lovisatti, S. Makimattila, A. Bertoldo, S. Weintraub, R. DeFronzo, C. Cobelli, and H. Yki-Jarvinen Direct measurement of the lumped constant for 2-deoxy-[1-14C]glucose in vivo in human skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E228 - E233. [Abstract] [Full Text] [PDF]